Former Gilead R&D chief to lead cancer drug startup in Cambridge
May 23, 2018 at 06:00 AM EDT
The company, Kronos Bio, formally launched on Wednesday with $18 million in seed financing.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.